NEW YORK (Reuters Health) - Nausea and vomiting occurring the week after cancer chemotherapy is common, despite the use of so-called "anti-emetics" to control nausea and vomiting, and can adversely ...

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting (CINV)Phase 3 study met all primary and secondary endpoints, demonstrating superior ...

Please provide your email address to receive an email when new articles are posted on . Patients assigned olanzapine achieved better nausea control than those assigned observation. More patients ...

(HealthDay News) — Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting. Varubi, a substance P/neurokinin-1 ...

(Reuters Health) - Adding the cheap antipsychotic drug olanzapine to conventional anti-vomiting medicine can help prevent nausea in cancer patients, according to a new test of 380 volunteers. During ...

Chemotherapy-induced nausea and vomiting (CINV) represents one of the most distressing and debilitating side effects experienced by cancer patients undergoing treatment, significantly impacting ...

Immunotherapy in EGFR-Mutant Non–Small Cell Lung Cancer: End of the Road or the First Chapter? Supported in part by the Harold and Shirley Lederman Chair in Psychosocial Oncology and Palliative Care, ...

Purpose: The physiology, risk factors, and prevention and treatment of postoperative nausea and vomiting (PONV) are discussed. Summary: Factors to consider when determining a patient's risk for PONV ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults taking NG101 had fewer semaglutide-induced events ...